XML 99 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Combinations (SARcode, Premacure and Lotus) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 6 Months Ended 6 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Lotus
Jun. 30, 2012
Lotus
Feb. 12, 2013
Lotus
Feb. 12, 2013
Lotus
purchase price allocation
Jun. 30, 2013
SARcode Biosciences Inc
Jun. 30, 2012
SARcode Biosciences Inc
Apr. 17, 2013
SARcode Biosciences Inc
Apr. 17, 2013
SARcode Biosciences Inc
purchase price allocation
Jun. 30, 2013
Premacure AB
Jun. 30, 2012
Premacure AB
Mar. 08, 2013
Premacure AB
Mar. 08, 2013
Premacure AB
purchase price allocation
Business Acquisition [Line Items]                                
Percentage of voting interests acquired             100.00%       100.00%       100.00%  
Cash consideration paid             $ 49.4       $ 151.0       $ 30.6  
Maximum amount of contingent cash consideration             275.0       525.0       169.0  
Integration and acquisition costs 17.4 7.1 21.5 12.4 3.7 0     4.6 0     4.2 0    
Acquisition-date fair value of consideration totaled             174.2       368.0       140.2  
Fair value of contingent consideration payable             124.8       217.0       109.6  
Net current assets assumed               6.8                
Goodwill         54.1     54.1 86.6     86.6       29.6
Net non-current liabilities assumed (including deferred tax liabilities)               63.4       122.4       29.5
IPR&D               176.7       412.0       151.8
Net current liabilities assumed                       $ 8.2       $ 11.7